ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 508

Non-Invasive Evaluation of Left Atrial Pressure in Hispanic Patients with Rheumatoid Arthritis: A Case-Control Study

José R. Azpiri-López1, Dionicio A. Galarza-Delgado2, Iris J. Colunga-Pedraza3, Jose A. Davila-Jimenez4, Estefania E. Abundis-Marquez4, Andres H. Guillen-Lozoya4, Francisco J. Torres-Quintanilla4, Aldo Valdovinos-Bañuelos4, Ray Ramos-Cázares4, Raymundo Vera-Pineda4, Jesus A. Cardenas-de la Garza4, Rosa I. Arvizu-Rivera4 and Adrián Martínez-Moreno4, 1Cardiology, Hospital Universitario, UANL, Monterrey, Mexico, 2Chief of Rheumatology, Hospital Universitario, UANL, Monterrey, Mexico, 3Rheumatology, Hospital Universitario, UANL, Monterrey, Mexico, 4Hospital Universitario, UANL, Monterrey, Mexico

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease, Comorbidity, Heart disease, prevention and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster I: Comorbidities

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

In the last several years a higher prevalence of heart failure has been described in Rheumatoid arthritis (RA) patients, particularly heart failure with preserved ejection fraction (HFpEF). Elevated left atrial pressure (LAP) may not only be a pathophysiologic substrate of symptoms in patients with HFpEF, it may also be direct prognostic markers.(1) Several studies have emphasized the importance of left atrial function in RA-patients. (2) Objective: to compare the LAP and diastolic left ventricle (LV) filling patterns between RA-patients and controls.

Methods:

A case-control study with RA patients aged 40 to 75 years that fulfilled the 2010 ACR/EULAR criteria and matching controls were included. Exclusion criteria: poor acoustic window, prior atherosclerotic cardiovascular (CV) disease and overlap syndromes. Patients were matched using age, sex and CV comorbidities. Transthoracic echocardiogram was performed by a board-certified cardiologist, and reviewed by two cardiologists. LAP was estimated using the Nagueh-formula [1.24 * (E/E’) + 1.9] and ASE’s guidelines were used to define elevated LAP and diastolic LV filling patterns.

Results:

A total of 80 RA-patients and 54 matched controls were included. Demographic and clinical characteristics are shown in Table 1. As shown in Table 2, the mean LAP was not significantly higher in RA-patients than controls (12.9 ± 3.6 vs 12.2 ± 2.5, P=0.18). The difference between elevated LAP prevalence was not significant among both groups (8.8% vs 5.6%, P=0.49). Abnormal diastolic LV filling pattern was more prevalent in RA-patients compared to controls. LAP showed null correlation with disease duration (r= 0.06 P= 0.64) and DAS 28-CRP (r=0.01 P=0.93).

Conclusion:

Left atrial pressure values were not different in Hispanic RA-patients evaluated when compared to controls and did not correlate with disease activity and duration. RA-patients had abnormal relaxation more frequently than controls.

  1. Hasenfuss G, et al. Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure Trial. J Card Fail. 2015;21(7):594–600.
  2. Maloberti A, et al. Association Between Atrial, Ventricular and Vascular Morphofunctional Alterations in RA. High Blood Press Cardiovasc Prev. 2018;25(1):97–104.

Table 1. Demographic and Clinical characteristics

RA

Control

P

(n=80)

(n=54)

Age, mean ± SD

55.3 ± 8.6

53.5 ± 6.3

0.182 (NS)

Women, n (%)

78 (97.5)

49 (90.7)

0.085 (NS)

Disease duration, mean ± SD

10.5 ± 8.5

–

–

DAS 28-CRP, mean ± SD

3.3 ± 1.31

–

–

DM type 2, n (%)

7 (8.8)

7 (13)

0.434 (NS)

Hypertension, n (%)

28 (35)

11 (20.4)

0.067 (NS)

Smoking, n (%)

6 (7.5)

6 (11.1)

0.473 (NS)

DAS 28-CRP – DAS 28 using C reactive protein, DM type 2 – Diabetes mellitus type 2, NS – Non-significant

Table 2. Echocardiographic findings

RA

Control

P

(n=80)

(n=54)

LAP (mmHg), mean ± SD

12.9 ± 3.6

12.2 ± 2.5

0.178 (NS)

Elevated LAP, n (%)

7 (8.8)

3 (5.6)

0.490 (NS)

E/E’, mean ± SD

8.88 ± 2.87

8.3 ± 2.06

0.206 (NS)

E/A, mean ± SD

1.05 ± 0.29

1.06 ± 0.32

0.855 (NS)

Diastolic LV filling pattern

Normal, n (%)

66 (82.5)

51 (94.4)

0.042

Impaired relaxation, n (%)

10 (12.5)

2 (3.7)

0.08 (NS)

Pseudonormal, n (%)

4 (5)

1 (1.9)

0.346 (NS)

Restrictive, n (%)

0 (0)

0 (0)

NS

LAP – Left atrial pressure, LV – Left ventricle, NS – Non-significant


Disclosure: J. R. Azpiri-López, None; D. A. Galarza-Delgado, None; I. J. Colunga-Pedraza, None; J. A. Davila-Jimenez, None; E. E. Abundis-Marquez, None; A. H. Guillen-Lozoya, None; F. J. Torres-Quintanilla, None; A. Valdovinos-Bañuelos, None; R. Ramos-Cázares, None; R. Vera-Pineda, None; J. A. Cardenas-de la Garza, None; R. I. Arvizu-Rivera, None; A. Martínez-Moreno, None.

To cite this abstract in AMA style:

Azpiri-López JR, Galarza-Delgado DA, Colunga-Pedraza IJ, Davila-Jimenez JA, Abundis-Marquez EE, Guillen-Lozoya AH, Torres-Quintanilla FJ, Valdovinos-Bañuelos A, Ramos-Cázares R, Vera-Pineda R, Cardenas-de la Garza JA, Arvizu-Rivera RI, Martínez-Moreno A. Non-Invasive Evaluation of Left Atrial Pressure in Hispanic Patients with Rheumatoid Arthritis: A Case-Control Study [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/non-invasive-evaluation-of-left-atrial-pressure-in-hispanic-patients-with-rheumatoid-arthritis-a-case-control-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/non-invasive-evaluation-of-left-atrial-pressure-in-hispanic-patients-with-rheumatoid-arthritis-a-case-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology